Source: PerkinElmer, Inc.

Turnkey Ozone Precursor Analyzers Offer Programmable Pneumatic Control for Maximum Ease-of-Use and Reliability

ORLANDO, Fla. – PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced five new systems for remote environmental air monitoring. PerkinElmer’s turnkey Ozone Precursor Analyzers combine the Clarus® 500 multidimensional Gas Chromatograph (GC) with the Company’s recently introduced family of TurboMatrix™ Thermal Desorbers to maximize ease-of-use and reliability for ozone precursor and air toxics analyses. The new systems, which offer integrated programmable pneumatic control (PPC), were unveiled at PITTCON® 2006, Booth 2669.

The new Ozone Precursor Analyzers build upon proven technology and methodology developed by PerkinElmer, in conjunction with the United States Environmental Protection Agency (EPA), to allow for the collection and measurement of C2 -C12 hydrocarbons automatically, without the use of liquid cryogen. This established method, which has been successfully implemented on PerkinElmer systems for many years, can now utilize state-of-the-art, integrated technologies incorporating PPC to offer total system remote control for complete, unattended operation.

“PerkinElmer is committed to providing innovative solutions to help manage the quality of the environment and its effect on human health,” said Jonathan Rennert, vice president and general manager, Analytical Sciences, for PerkinElmer’s Life and Analytical Sciences division. “By integrating our Clarus GC with our TurboMatrix Thermal Desorbers, PerkinElmer is providing true remote operation, flexibility and ease-of-use for ozone precursor and air toxics analyses, while continuing to deliver a complete, single-vendor solution for gas chromatography.”

The five new Ozone Precursor Analyzers, incorporating PerkinElmer’s TurboMatrix 100 TD, 150 ATD, 300 TD, 350 ATD, and 650 ATD Thermal Desorber models, also enable customers to match technology to meet their specific laboratory needs by providing both single-sample and automated 50-sample configurations, with either manual or fully integrated PPC configurations. Other key features and user benefits include:

Easy setup and maximum reliability – With integrated PPC functionality, the new Ozone Precursor Analyzers allow for drift-free operation and easy setup of pressure and flow control, automatically taking into account pressure-drop relationships with trap impedance, different column and transfer-line dimensions, as well as temperature and carrier gas type.

Efficient system integrity monitoring – The new Ozone Precursor Analyzer, incorporating the TurboMatrix 650 ATD Thermal Desorber, offers a fully-automated procedure to measure variances in trap impedance to establish specifications or initial values. Trap impedance measurements against initial values optimize QC efficiency and traps maintained in optimum condition enhance confidence in analytical data.

Enhanced ease-of-use and adaptability – With a few quick presses on the intuitive, color touch-screen user interface on both the Thermal Desorber and the GC, the new Ozone Precursor Analyzers allow users to set parameters and start sampling utilizing any one of eight operating languages, including English, Japanese, Chinese, French, German, Italian, Spanish or Russian.

Single point-of-control – The TurboMatrix Remote Control Software (RCS) supports TotalChrom® to provide integral control of the thermal desorber’s methods and sequences. Configured in this way, TotalChrom serves as a single point-of-control for the complete system, including the TurboMatrix Thermal Desorber, Clarus GC and data handling. Using an external application, such as pcAnywhere™, allows total-system remote control along with automatic data archival via the Internet, LAN or dial-up modem.

For more information on the new Ozone Precursor Analyzers, please visit:

Factors Affecting Future Performance

This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as “believes,” “intends,” “anticipates,” “plans,” “expects,” “projects,” “forecasts,” “will” and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management’s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) economic and geopolitical forces that may limit any continued or expected economic or end market strengthening or recoveries; (2) risks related to our failure to introduce new products in a timely manner; (3) our ability to comply with financial covenants contained in our credit agreements and our debt instruments; (4) a delay in resolution of the Company’s tax audits and an adverse determination with respect to the Company’s tax audits by the Internal Revenue Service or other taxing authorities; (5) cyclical downturns continuing to affect several of the industries into which we sell our products; (6) our ability to adjust our operations to address unexpected changes; (7) our ability to execute acquisitions and license technologies and successfully integrate acquired businesses and licensed technologies into our existing business; (8) the loss of any of our licenses that may require us to stop selling products or lose competitive advantage; (9) competition; (10) regulatory compliance; (11) regulatory changes; (12) our failure to obtain and enforce intellectual property protection; (13) our defense of third party claims of patent infringement and our ability to realize the full value of our intangible assets; (14) other factors which we describe under the caption “Forward-Looking Information and Factors Affecting Future Performance” in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

Other Information

Health Sciences end markets include genetic screening, environmental, service, biopharma, and medical imaging. Photonics markets include sensors and specialty lighting.

PerkinElmer, Inc. is a global technology leader driving growth and innovation in Health Sciences and Photonics markets to improve the quality of life. The Company reported revenues of $1.5 billion in 2005, has 8,000 employees serving customers in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through or 1-877-PKI-NYSE.

Customer comments